Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123149804 | 12314980 | 4 | F | 2011 | 20160726 | 20160428 | 20160728 | EXP | US-JNJFOC-20160417085 | JANSSEN | 0.00 | A | F | Y | 0.00000 | 20160728 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123149804 | 12314980 | 1 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | Y | N | UNKNOWN;UNKNOWN | 0 | SOLUTION FOR INJECTION | |||||||
123149804 | 12314980 | 2 | PS | STELARA | USTEKINUMAB | 1 | Subcutaneous | Y | N | UNKNOWN;UNKNOWN | 125261 | SOLUTION FOR INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123149804 | 12314980 | 1 | Psoriasis |
123149804 | 12314980 | 2 | Psoriasis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
123149804 | 12314980 | OT |
123149804 | 12314980 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123149804 | 12314980 | Drug effect decreased | |
123149804 | 12314980 | Exposure during pregnancy | |
123149804 | 12314980 | Psoriasis | |
123149804 | 12314980 | Psoriatic arthropathy | |
123149804 | 12314980 | Wound infection staphylococcal |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
123149804 | 12314980 | 1 | 2011 | 0 |